EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isolated Anti‐ SS ‐A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases

Nana Ishida, Kazuki M Matsuda iD, Hirohito Kotani iD, Hayakazu Sumida, Shinichi Sato

The Journal of Dermatology · 2026

DOI: 10.1111/1346-8138.70055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Dermatology, 2026. Verfasst von Nana Ishida und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Scleroderma, Systemic, Antibodies, Antinuclear. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis is an autoimmune disease characterized by vasculopathy, fibrosis, and immune dysregulation. Anti‐SS‐A antibodies (anti‐SSA) have been reported to confer severe clinical manifestations in some Western and Japanese cohorts. We aimed to determine whether anti‐SSA seropositivity affects clinical outcomes in Japanese patients. We retrospectively analyzed 307 Japanese patients with systemic sclerosis who underwent initial evaluation between January 2011 and March 2020 in our clinic. “Isolated” anti‐SSA seropositivity was defined as positivity for anti‐SSA in the absence of anti‐topoisomerase I, anti‐centromere, anti‐RNA polymerase III, and anti‐U1 ribonucleoprotein antibodies. Overall survival was defined as time to all‐cause mortality, and progression‐free survival was defined as time to disease progression necessitating intensified therapy. Cox proportional hazards models were employed to estimate hazard ratios and 95% confidence intervals. For patients with “isolated” anti‐SSA seropositivity, further investigation for SSc‐related autoantibodies was conducted utilizing Autoantibody Array Assay (A‐Cube). Anti‐SSA were detected in 31.3% of patients. Although anti‐SSA seropositivity overall correlated with interstitial lung disease, it was not independently associated with overall survival or progression‐free survival. In contrast, “isolated” anti‐SSA seropositivity emerged as an independent risk factor for both shorter overall survival (hazard ratio 21.7, 95% confidence interval 5.57–84.8) and progression‐free survival (hazard ratio 4.18, 95% confidence interval 1.05–16.7). Expanded serologic testing revealed additional autoantibodies implicated in severe SSc phenotypes. These findings underscore the importance of routinely assessing anti‐SSA and highlight the need for autoantibody screening in depth in this subpopulation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Scleroderma, SystemicAntibodies, AntinuclearHumansFemaleMaleRetrospective StudiesMiddle AgedPrognosisAdultAgedJapanDisease ProgressionProgression-Free SurvivalLung Diseases, InterstitialAutoantibodies

Stichwörter der Autor:innen

Cox regression analysisSSAautoantibodyinterstitial lung diseasesystemic sclerosis

Substanzen

Antibodies, AntinuclearSS-A antibodiesAutoantibodies

Autor:innen und Institutionen

  • Department of Dermatology, The University of Tokyo Graduate School of Medicine, Tokyo, Japan.
  • Scleroderma Center, The University of Tokyo Hospital, Tokyo, Japan.
  • SLE Center, The University of Tokyo Hospital, Tokyo, Japan.

ORCID-Profile: Kazuki M Matsuda, Hirohito Kotani

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Ishida, N., Matsuda, K. M., Kotani, H., Sumida, H., & Sato, S. (2026). Isolated Anti‐ SS ‐A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases. The Journal of Dermatology. https://doi.org/10.1111/1346-8138.70055

Vancouver

Ishida N, Matsuda KM, Kotani H, Sumida H, Sato S. Isolated Anti‐ SS ‐A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases. The Journal of Dermatology. 2026. doi:10.1111/1346-8138.70055

BibTeX
@article{Ishida2026,
  author = {Ishida, Nana and Matsuda, Kazuki M and Kotani, Hirohito and Sumida, Hayakazu and Sato, Shinichi},
  title = {Isolated Anti‐ SS ‐A Antibody Seropositivity as a Poor Prognostic Factor in Systemic Sclerosis: Insights From a Cohort of 307 Cases},
  journal = {The Journal of Dermatology},
  year = {2026},
  doi = {10.1111/1346-8138.70055}
}
Kostenlos starten →